Medifast (NYSE: MED) reported third-quarter 2026 revenue of $72.0 million, down 19.4% from $89.4 million a year earlier. The company posted a net loss of $17.5 million, or $1.57 per diluted share, for the quarter ended September 30.
Active earning coaches declined 47.7% year over year to 10,200, while revenue per active earning coach rose 54.1% to $7,064. Medifast ended the quarter with $172.5 million in cash, cash equivalents and investment securities and no debt.
- GAAP gross profit was $50.0 million, down 19.5% from the prior-year quarter.
- Selling, general and administrative expense increased 4.8% to $69.4 million, including Catalyst Restructuring charges.
- Loss from operations was $19.4 million, compared with a $4.1 million loss a year earlier.
- Fourth-quarter 2026 revenue guidance is $55 million to $75 million, with income per share expected between $0.00 and $0.25.
- Full-year 2026 revenue guidance is $280 million to $300 million, with loss per share projected at $1.80 to $2.05.
$MED Insider Trading Activity
$MED insiders have traded $MED stock on the open market 10 times in the past 6 months. Of those trades, 8 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MED stock by insiders over the last 6 months:
- PARSA KIAI has made 8 purchases buying 119,966 shares for an estimated $1,423,802 and 0 sales.
- DANIEL R CHARD has made 0 purchases and 2 sales selling 19,089 shares for an estimated $226,288.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MED Hedge Fund Activity
We have seen 52 institutional investors add shares of $MED stock to their portfolio, and 62 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 574,950 shares (-60.9%) from their portfolio in Q2 2026, for an estimated $6,100,219
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 396,996 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,212,127
- MARSHALL WACE, LLP added 241,649 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,563,895
- MAN GROUP PLC removed 236,500 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $2,509,265
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 234,543 shares (-37.1%) from their portfolio in Q2 2026, for an estimated $2,488,501
- TWO SIGMA INVESTMENTS, LP added 143,223 shares (+42.4%) to their portfolio in Q2 2026, for an estimated $1,519,596
- GEODE CAPITAL MANAGEMENT, LLC removed 132,244 shares (-52.2%) from their portfolio in Q2 2026, for an estimated $1,403,108
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
